Agents and Actions

, Volume 30, Issue 1–2, pp 98–101 | Cite as

A pertussis toxin-sensitive G protein is required to induce histamine release from rat peritoneal mast cells by bradykinin

  • J. L. Bueb
  • M. Mousli
  • Y. Landry
  • C. Bronner
Histamine Release


Bradykinin, kallidin (Lys-bradykinin) and [Thi5,8,d-Phe7]-bradykinin a functional B2 antagonist, induce histamine release from rat peritoneal mast cells. The histamine release is dependent upon added calcium when mast cells are placed in calcium-free medium 30 min before being triggered with the kinins. Histamine release was dose-dependently inhibited by pertussis toxin (1–100 ng/ml) and by benzalkonium chloride (0.1–3 μg/ml). The efficiency of ionophore A23187 on histamine release was affected neither by pertussis toxin nor by benzalkonium chloride. The parallel responses of rat peritoneal mast cells to kinins and to substance P suggest that these peptides have the same mechanisms of action i.e. activation of a pertussis toxin-sensitive G protein and of phospholipase C defining a peptidergic triggering pathway of mast cells.


Calcium Peptide Chloride Mast Cell Histamine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    M. Mousli, C. Bronner, J. L. Bueb, E. Tschirhart, J. P. Gies and Y. Landry,Activation of rat peritoneal mast cells by substance P and mastoparan. J. Pharmacol. exp. Ther.250, 329–335 (1989).PubMedGoogle Scholar
  2. [2]
    P. Devillier, M. Renoux, G. Drapeau and D. Regoli,Histamine release from rat peritoneal mast cells by kinin antagonists. Eur. J. Pharmacol.149, 137–140 (1988).PubMedGoogle Scholar
  3. [3]
    I. D. Lawrence, J. A. Warner, V. L. Cohan, L. M. Lichtenstein, A. Kagey-Sobotka, R. J. Vavrek, J. M. Stewart and D. Proud,Induction of histamine release from human skin mast cells by bradykinin analogs. Biochem. Pharmacol.38, 227–233 (1989).PubMedGoogle Scholar
  4. [4]
    D. Regoli and J. Barabé,Pharmacology of bradykinin and related kinins. Pharmacol. Rev.32, 1–46 (1980).PubMedGoogle Scholar
  5. [5]
    G. W. Read and E. F. Kiefer,Benzalkonium chloride: selective inhibitor of histamine release induced by compound 48/80 and other polyamines. J. Pharmacol. exp. Ther.211, 711–715 (1979).PubMedGoogle Scholar
  6. [6]
    M. A. Lowman, R. C. Benyon and M. K. Church,Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br. J. Pharmacol.95, 121–130 (1988).PubMedGoogle Scholar
  7. [7]
    F. L. Pearce, T. A. Kassessinoff and W. L. Liu,Characteristics of histamine secretion induced by neuropeptides: implications for the relevance of peptide-mast cell interactions in allergy and inflammation. Int. Arch. Allergy appl. Immunol.88, 129–131 (1989).PubMedGoogle Scholar
  8. [8]
    C. Bronner, J. P. Gies, A. Vallé and Y. Landry,Preservation of the secretory response of peritoneal mast cells in the absence of extracellular calcium. Life Sci.41, 2555–2562 (1987).PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1990

Authors and Affiliations

  • J. L. Bueb
    • 1
  • M. Mousli
    • 1
  • Y. Landry
    • 1
  • C. Bronner
    • 1
  1. 1.Laboratoire de NeuroimmunopharmacologieUniversité Louis Pasteur-Strasbourg IIllkirchFrance

Personalised recommendations